Should chitosan and tranexamic acid be combined for improved hemostasis after sinus surgery?

Medical Hypotheses

Volumn 81, Issue 6, 2013, Pages 1036-1038

  Bartley, Jim ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; MORPHINE; TRANEXAMIC ACID;

ARTICLE; BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENDOSCOPIC SINUS SURGERY; HEMOSTASIS; HUMAN; HYPOTHESIS; NONHUMAN; WOUND HEALING;

ADMINISTRATION, TOPICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; HEMOSTASIS, SURGICAL; HUMANS; MODELS, BIOLOGICAL; PARANASAL SINUSES; TRANEXAMIC ACID;

EID: 84888432941     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.09.027     Document Type: Article

References (36)

1. Dai T., Tanaka M., Huang Y.-Y., Hamblin M. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev Anti Infect Ther 2011, 9:657-679.
2. Luppi B., Bigucci F., Cerchiara T., Zecchi V. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin Drug Deliv 2010, 7:811-828.
3. Klokkevold P., Lew D., Ellis D., Bertolami C.N. The effect of chitosan on lingual hemostasis in rabbits. J Oral Maxillofac Surg 1991, 49:858-863.
4. Gustafson S.B., Fulkerson P., Bildrell R., Aguilera L., Hazzard T.M. Chitosan dressing provides hemostasis in swine femoral arterial injury model. Prehosp Emerg Care 2007, 11:172-178.
5. Valentine R., Athanasiadis T., Moratti S., Hanton L., Robinson S., Wormald P.-J. The efficacy of a novel chitosan gel on hemostasis and wound healing after endoscopic sinus surgery. Am J Rhinol Allergy 2010, 24:70-75.
6. Pusateri A., McCarthy S., Gregory K., Harris R.A., Cardenas L., McManus A.T., et al. Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma 2003, 54:177-182.
7. Sohn V., Eckert M., Martin M., Arthurs Z.M., Perry J.R., Beekley A., et al. Efficacy of three topical hemostatic agents applied by medics in a lethal groin injury model. J Surg Res 2009, 154:258-261.
8. Ong S., Wu J., Moochhala S., Tan M., Lu J. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 2008, 29:4323-4332.
9. Kozen B., Kircher S., Henao J., Godinez F.S., Johnson A.S. An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuikClot. Acad Emerg Med 2008, 15:74-81.
10. Millner R.W., Lockhart A.S., Bird H., Alexiou C. A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery. Ann Thorac Surg 2009, 87:e13-e14.
11. Kranokpiraksa P., Pavcnik D., Kakizawa H., Uchida B., Jeromel M., Keller F., et al. Hemostatic efficacy of chitosan-based bandage for closure of percutaneous arterial access sites: an experimental study in heparinized sheep model. Radiol Oncol 2010, 44:86-91.
12. Chou T., Fu E., Wu C., Yeh J. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun 2003, 302:480-483.
13. Okamoto Y., Yano R., Miyatake, Tomohiro I., Shigemasa Y., Minami S. Effects of chitin and chitosan on blood coagulation. Carbohydr Polym 2003, 53:337-342.
14. Dai T., Tegos G., Burkatovskaya M., Castano A., Hamblin M. Chitosan acetate bandage as a topical antimicrobial dressing for infected burns. Antimicrob Agents Chemother 2009, 53:393-400.
15. Muzzarelli R.A.A. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr Polyme 2009, 76:167-182.
16. Muzzarelli R.A. Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar Drugs 2010, 8:292-312.
17. Ong S.Y., Wu J., Moochhala S.M., Tan M.H., Lu J. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 2008, 29:4323-4332.
18. Smart J. The basics and underlying mechanisms of mucoadhesion. Adv Drug Del Rev 2005, 57:1556-1568.
19. Duchene D., Touchard F., Peppas N. Pharmaceutical and medical aspects of bioadhesive systems for drug administrations. Drug Dev Ind Pharm 1988, 14:283-318.
20. Aspden T., Mason J., Jones N., Lowe J., Skaugrud O., Illum L. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 1997, 86:509-513.
21. Smith J., Wood E., Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm Res 2004, 21:43-49.
22. Dodane V., Khan M., Merwin J. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999, 182:21-32.
23. Schipper N., Varum K., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res 1996, 13:1686-1692.
24. Rossi S., Marciello M., Bonferoni M.C., Ferrari F., Sandri G., Dacarro C., et al. Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis. Eur J Pharm Biopharm 2010, 74:248-254.
25. Pavis H., Wilcock A., Edgecombe J., Carr D., Manderson C., Church A., et al. Pilot study of nasal morphine - chitosan for the relief of breakthrough pain in patients with cancer. J Pain Symptom Manage 2002, 24:598-602.
26. Stoker D., Reber K., Waltzman L., Gawarecki D., Mermelstein F., McNicol E., et al. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery. Pain Med 2008, 9:3-12.
27. Christensen K.S., Cohen A.E., Mermelstein F.H., Hamilton D.A., McNicol E., Babul N., et al. The analgesic efficacy and safety of a novel intranasal morphine formulation (morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model. Anesth Analg 2008, 107:2018-2024.
28. Longstaff C. Studies on the mechanisms of action of Aprotonin and Tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 1994, 5:537-542.
29. Verstraete M. Clinical applications of inhibitors of fibrinolysis. Drugs 1985, 29:236-261.
30. Ker K., Edwards P., Rerei P., Shakur H., Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012, 344:e3054.
31. Sindet-Pedersen S., Ramstrom G., Bernvil S., Blomback M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989, 320:840-843.
32. Albirmawy O., Saafan M., Shehata E., Basuni A., Eldaba A. Topical application of tranexamic acid after adenoidectomy: a double-blind, prospective, randomized, controlled study. Int J Pediatr Otorhinolaryngol 2013, Epub ahead of print.
33. Ipema H., Tanzi M. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother 2012, 46:97-107.
34. Dell'Amore A., Caroli G., Nizar A., Cassanelli N., Luciano G., Greco D., et al. Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation. Heart Lung Circ 2012, 21:706-710.
35. Athanasiadis T., Beule A., Wormald P. Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial. Am J Rhinol 2007, 6:737-742.
36. Li D., Li P., Zang J., Liu J. Enhanced hemostatic performance of tranexamic acid-loaded chitosan/alginate composite microparticles. J Biomed Biotechnol 2012, 981321.